Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Non-cash Items (2016 - 2018)

Alaunos Therapeutics (TCRT) has disclosed Non-cash Items for 8 consecutive years, with $576000.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Non-cash Items fell 78.64% year-over-year to $576000.0, compared with a TTM value of $576000.0 through Sep 2018, down 78.64%, and an annual FY2017 reading of $1.2 million, down 56.88% over the prior year.
  • Non-cash Items was $576000.0 for Q3 2018 at Alaunos Therapeutics, down from $2.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $39.6 million in Q1 2015 and bottomed at $576000.0 in Q3 2018.
  • Average Non-cash Items over 5 years is $5.6 million, with a median of $2.8 million recorded in 2018.
  • The sharpest move saw Non-cash Items surged 706.37% in 2014, then crashed 94.64% in 2016.
  • Year by year, Non-cash Items stood at $3.8 million in 2014, then plummeted by 43.91% to $2.1 million in 2015, then increased by 25.98% to $2.7 million in 2016, then grew by 9.49% to $2.9 million in 2017, then crashed by 80.31% to $576000.0 in 2018.
  • Business Quant data shows Non-cash Items for TCRT at $576000.0 in Q3 2018, $2.8 million in Q2 2018, and $3.0 million in Q1 2018.